DAY 53

Health & Longevity: The Story of Blood
Anemia, Iron, Lipids & Clotting

2026-07-09 · BigCat's Vitality Protocol

Evidence this issue: lipids & thrombosis mostly RCT + large cohorts; iron metabolism & anemia typing mostly mechanistic studies + expert consensus

SUB · Anemia / Red Cells

Anemia Is a Sign, Not a Diagnosis

Find the cause behind the low hemoglobin

One-Line Takeaway

"Anemia" only means red cells or hemoglobin are low — it's the effect, not the cause. Every case must be worked up further, and mean cell volume (MCV) is the fastest triage signpost: small, normal, or large point to entirely different problems.

Evidence Level

Expert consensus + mechanism: WHO thresholds — Hb <120 g/L (non-pregnant women), <110 (pregnancy), <130 (men). Iron deficiency is the most common cause worldwide, hitting women of reproductive age far more than men (WHO global anemia report). Camaschella (NEJM 2015) established the MCV + ferritin diagnostic path.

Science & Mechanism

Red cells carry oxygen entirely via the iron in hemoglobin. A shortage of any raw material (iron, B12, folate), red cells destroyed too fast (hemolysis), or suppressed production (chronic disease, kidney, marrow) all present as anemia. MCV is a great signpost because cells take the shape of what's missing — small when iron-deficient, large when B12/folate-deficient.

Microcytic MCV<80
Iron deficiency, thalassemia, chronic inflammation

Normocytic 80–100
Acute blood loss, chronic/renal disease, hemolysis

Macrocytic MCV>100
B12/folate deficiency, hypothyroidism, alcohol

MCV = mean corpuscular volume (fL). This is a triage map, not an endpoint — each branch still needs ferritin, B12, reticulocyte count to localize further.

Actionable Protocol

• Base panel: CBC for Hb + MCV + reticulocytes
• Microcytic → check ferritin + transferrin saturation; if ferritin looks normal but iron deficiency is suspected, check CRP (inflammation falsely raises ferritin)
• Macrocytic → check B12, folate, thyroid (TSH)
• Key move: finding iron deficiency ≠ done. New iron deficiency in a post-menopausal woman or any man demands a GI workup for chronic bleeding (including cancer)

For Women + Common Myths

Iron deficiency, the most common form in women of reproductive age, usually traces to heavier periods (~15–30 mg iron lost per period): note frequent pad/tampon changes or large clots. In pregnancy, expanded blood volume "dilutes" Hb — this is physiological, and ferritin reflects true status better than Hb.

Myth 1: "Anemia means iron deficiency, just take iron" — iron does nothing for macrocytic anemia and can mask a B12 deficiency.
Myth 2: "Normal Hb means iron is fine" — iron stores empty first (low ferritin) while Hb is still normal — "latent" iron deficiency.

Try This Week + Reflection

THIS WEEK

Pull your latest lab report, find Hb and MCV, and classify yourself on the map above; if you've never checked ferritin alone, add it to your next blood draw. Reflect: when is a value "low within the normal range" worth chasing, and when is it overmedicalization?

SUB · Iron Metabolism / Ferritin

Iron Metabolism — Storage Beats Intake

Absorption is gated by a hormone, not by how much you swallow

One-Line Takeaway

The body has no active route to excrete iron; the whole system runs on hepcidin controlling the absorption gate. Dosing iron every other day absorbs better than "several times daily" — because each dose briefly shuts the gate.

Evidence Level

RCT: Stoffel (Lancet Haematol 2017 / Haematologica 2020) showed a single large oral iron dose raises hepcidin within 24 h and suppresses next-day absorption; alternate-day or once-daily gives higher cumulative absorption and fewer side effects than multiple daily doses. Ganz's hepcidin work established the modern view that iron balance is controlled by a liver hormone.

Science & Mechanism

Ferritin reads out iron storage, but it's also an acute-phase reactant — infection, inflammation, and obesity inflate it. So a low ferritin still proves true deficiency, while a normal one isn't necessarily reassuring. Hepcidin is the master gate: it rises with iron excess or inflammation, locking down gut absorption — which explains "anemia of chronic disease," where iron is plentiful but trapped in stores. Iron's side effects come mostly from unabsorbed iron irritating the gut, so fewer doses means fewer side effects.

Actionable Protocol

• Dose: oral elemental iron 40–60 mg, every other day (or once daily — not multiple times a day)
• Absorption: empty stomach or with vitamin C; separate from calcium, coffee, tea, acid blockers (PPIs)
• Duration: after Hb normalizes, continue 2–3 more months to refill ferritin (target >50 μg/L), or it relapses
• Recheck: at 4–8 weeks look for a rise in Hb and reticulocytes; no response → re-investigate the cause
• IV iron: an efficient option when oral is not tolerated or deficiency is severe — assess with a physician

For Women + Common Myths

Iron needs roughly double month by month in pregnancy, especially later, and deficiency links to preterm birth and low birth weight. Those with heavy periods can concentrate iron around menses; perimenopausal surges in flow are another hidden window for iron deficiency.

Myth 1: "More iron is always better" — men and post-menopausal women have no menstrual losses; blind loading risks iron overload (especially hemochromatosis carriers).
Myth 2: "Red dates / e'jiao / brown sugar build blood" — their iron content is tiny and poorly-absorbed non-heme iron; they won't correct real deficiency.

Try This Week + Reflection

THIS WEEK

If you take iron: switch to every other day, pair with vitamin C, and space it 2 h from milk/coffee — see if your gut feels better. Reflect: why is the management logic opposite for substances with an exit route versus those with intake-only?

SUB · Lipids / CV Risk

The Full Lipid Panel — Read ApoB, Not Just LDL-C

Count the particles, don't just weigh the cholesterol

One-Line Takeaway

The real culprit in atherosclerosis is the number of ApoB-carrying particles burrowing into the artery wall. ApoB counts particles directly — more accurate than LDL-C (an estimate of cholesterol weight). Also measure Lp(a) at least once in your life.

Evidence Level

RCT + Mendelian randomization: Ference et al. established a causal, dose-dependent link between ApoB/LDL and coronary disease; Sniderman (JAMA Cardiol 2019) meta-analysis shows ApoB discriminates risk better than LDL-C or non-HDL. Lp(a): Tsimikas (JACC 2017) review — ~1 in 5 people are genetically elevated, independently raising MI and aortic stenosis risk beyond LDL.

Science & Mechanism

Every LDL, VLDL, and Lp(a) particle carries one ApoB, so ApoB = total atherogenic particle count. When particles are small and numerous, LDL-C (which measures cholesterol weight) can look "normal" while particle number is high — that's why LDL-C alone misses cases. Particles slip under the endothelium, oxidize, and pile up as plaque over decades. The triglyceride/HDL ratio is a cheap proxy for insulin resistance — a high ratio suggests many small, dense LDL.

Marker	Meaning	Ideal / target (average risk)
ApoB	Total atherogenic particle count (core)	< 0.8 g/L, lower is better
LDL-C	Weight of LDL cholesterol	< 2.6 mmol/L; lower if high-risk
non-HDL-C	Total − HDL, all bad particles	LDL-C target + 0.8
Lp(a)	Genetic, independent risk	Test once; < 75 nmol/L
TG/HDL	Insulin-resistance proxy	< 2 (mg/dL units)

Actionable Protocol

• Add-ons: beyond a standard panel, request ApoB; measure Lp(a) at least once in life
• High Lp(a) (genetic, hard to change with lifestyle) → drive ApoB/LDL lower more aggressively to offset total risk
• Levers to lower ApoB: cut saturated fat, add soluble fiber, regular aerobic + strength; if off-target, a physician starts statins etc. per risk
• Skip the fasting obsession: non-fasting lipids are essentially adequate for risk (endorsed by European guidelines)

For Women + Common Myths

After menopause, estrogen withdrawal often bumps LDL and Lp(a) up a level, and risk converges toward men's — the key mid-life window to recheck lipids (physiological pregnancy rises don't count). Don't skip ApoB just because you're "young/lean."

Myth 1: "Higher HDL is always better" — very high HDL isn't necessarily protective, and drugs that force HDL up have all failed in trials.
Myth 2: "Lean people don't need lipid testing" — Lp(a) and familial hypercholesterolemia are genetic, unrelated to body weight.

Try This Week + Reflection

THIS WEEK

Pull your lipid report; if it only has LDL-C, add ApoB + a one-time Lp(a) to your next draw. Reflect: when a "weight metric" and a "count metric" disagree, which would you trust, and why?

SUB · Coagulation / Thrombosis

Clotting & Thrombosis — When a Lifesaver Turns

The right mechanism in the wrong place

One-Line Takeaway

Clotting is a lifesaving design for stopping bleeds, but out of control it blocks vessels in the wrong place. Risk comes mainly from Virchow's triad: stasis, vessel injury, hypercoagulability — and sitting, long flights, estrogen, and surgery hit exactly these.

Evidence Level

RCT + cohort: Virchow's triad is the classic consensus mechanism for VTE; atrial-fibrillation stroke prevention is stratified by CHA₂DS₂-VASc (Lip 2010, in every guideline). Aspirin for primary prevention: ASPREE, ARRIVE, ASCEND (three large 2018 RCTs) consistently showed unclear net benefit in healthy people with bleeding offsetting gains; USPSTF 2022 downgraded the recommendation accordingly.

Science & Mechanism

Arterial thrombi arise mostly from plaque rupture + platelet aggregation (heart attack, ischemic stroke); venous thrombi from stasis + hypercoagulability (DVT, pulmonary embolism) — which is why the drugs are opposite: antiplatelets for arteries, anticoagulants for veins/AFib. D-dimer is sensitive but not specific: a negative reasonably rules out acute clot, but a positive can come from infection, surgery, or pregnancy and cannot make a diagnosis alone.

Actionable Protocol

• Sitting/travel: stand up every 1–2 h, do ankle pumps while seated; on flights >4 h with risk factors wear medical compression stockings, hydrate well
• Post-op/immobile: prophylactic anticoagulation per your doctor + mobilize early
• Spot DVT/PE: one-sided calf swelling/pain, sudden breathlessness, chest pain, hemoptysis → ER, don't wait
• Aspirin: routine only for established CV disease (secondary prevention); no longer a default for primary prevention in healthy people — an individualized call by risk of bleeding

For Women + Common Myths

Combined estrogen oral contraceptives raise VTE risk about 2–4× (absolute risk still low); smoking, obesity, and a family history of thrombophilia stack on top — disclose family clot history before starting. Pregnancy and the 6 weeks postpartum are a natural hypercoagulable window. For perimenopausal HRT, choose transdermal (patch/gel) estrogen over oral to markedly avoid this VTE risk.

Myth 1: "A daily aspirin prevents clots and keeps me safe" — in healthy people without CV disease, bleeding risk often outweighs benefit.
Myth 2: "Clots are an old person's disease" — the pill + sitting + long flights hit young women too.

Try This Week + Reflection

THIS WEEK

Set an hourly stand-up reminder for sitting; before your next long trip, put "hydrate + ankle pumps + walk" on your checklist. If you self-take aspirin as "prevention," confirm with a doctor this week whether you're primary or secondary prevention. Reflect: have you truly counted the hidden cost of a "just-in-case" daily drug?

Deeper Reflection

① Should the "latent" iron stage (low ferritin, still-normal Hb) be treated?

With stores empty but Hb intact, people may already feel fatigue, hair loss, and reduced endurance. Waiting for Hb to drop into "anemia" wastes a low-cost window. The sensible move is to weigh symptoms plus the ferritin trend, not defend one red line — while resisting the urge to blame all fatigue on iron and over-supplement. Ask the cause first, then decide whether to treat.

② If ApoB is more accurate, why do most panels still give only LDL-C?

Inertia and cost. LDL-C is cheap, has vast historical data, anchors the guidelines, and every clinician knows it; ApoB needs an extra assay and the "particle count" idea is less familiar. It's a classic lag between evidence and practice — what you can do is request the add-on and decide with the more mechanism-aligned metric, rather than wait for the default to update.

③ What does aspirin's fall from "one for everyone" to "no longer default" teach us?

A "sound mechanism" isn't the same as "net benefit." Aspirin does inhibit platelets, but in low-risk primary-prevention people the baseline clot risk is small while bleeding risk is real, so benefit and cost roughly cancel. Every preventive intervention must be judged on absolute risk and net effect, not a one-sided "it lowers some risk" story — low-risk groups are where overtreatment concentrates.

④ Why do arterial and venous "clots" use nearly opposite preventive drugs?

Different causes: arterial clots are driven by plaque rupture with platelets as the lead actor, so you use antiplatelets; venous clots by stasis and hypercoagulability with clotting factors as the lead, so you use anticoagulants. Under one appearance (a clot), the branch in mechanism dictates the branch in treatment — therapy must always land on the correct link in the mechanistic chain.

⑤ Why is women's blood risk so often systematically underestimated?

Historical research skewed male, so risk models and reference ranges are largely calibrated to men. Women have a distinct blood rhythm: menstrual iron loss, the pill and pregnancy hypercoagulability, and the post-menopausal lipid jump. These aren't "diluted male versions" but independent dimensions needing their own models. Recognizing which physiological stage you're in beats applying a gender-neutral average.

← Back to Index